Data gathered: October 25
Alternative Data for Adaptive Biotechnologies
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 5 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 21,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 29 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 8 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,802 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,204 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 4,283 | Sign up | Sign up | Sign up |
| Twitter Followers | 4,577 | Sign up | Sign up | Sign up |
| Twitter Mentions | 24 | Sign up | Sign up | Sign up |
| X Mentions | 1 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 55 | Sign up | Sign up | Sign up |
| Linkedin Employees | 651 | Sign up | Sign up | Sign up |
About Adaptive Biotechnologies
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
| Price | $17.22 |
| Target Price | Sign up |
| Volume | 1,070,000 |
| Market Cap | $2.61B |
| Year Range | $6.67 - $17.83 |
| Dividend Yield | 0% |
| Analyst Rating | 71% buy |
| Earnings Date | November 5 '25 |
| Industry | Biotechnology |
In the news
 |
Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025October 15 - Yahoo |
 |
Adaptive Biotechnologies: Current Moat Is Strong, But Value Rides On Long-Term Innovation (Rating Upgrade)October 5 - SeekingAlpha |
 |
Analysts Set Adaptive Biotechnologies Corporation (NASDAQ:ADPT) PT at $13.22October 4 - ETF Daily News |
|
Guggenheim Initiates Coverage on Adaptive Biotechnologies (NASDAQ:ADPT)October 2 - ETF Daily News |
 |
Adaptive Biotechnologies initiated with bullish view at GuggenheimSeptember 30 - Thefly.com |
|
The Bull Case For Adaptive Biotechnologies (ADPT) Could Change Following Analyst Upgraded Earnings OutlookSeptember 27 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 59M | 18M | 41M | -26M | -18M | -0.170 |
| Q1 '25 | 52M | 17M | 35M | -30M | -30M | -0.200 |
| Q4 '24 | 47M | 18M | 29M | -34M | -26M | -0.230 |
| Q3 '24 | 46M | 17M | 30M | -32M | -25M | -0.220 |
| Q2 '24 | 43M | 22M | 21M | -46M | -39M | -0.310 |
Insider Transactions View All
| PISKEL KYLE filed to sell 277,396 shares at $8.9. May 19 '25 |
| PISKEL KYLE filed to sell 269,581 shares at $8.9. May 20 '25 |
| ROBINS HARLAN S filed to sell 1,279,524 shares at $7.4. May 5 '25 |
| ROBINS HARLAN S filed to sell 1,279,524 shares at $9. March 26 '25 |
| GRIFFIN MICHELLE RENEE filed to sell 15,394 shares at $7.2. March 17 '25 |
Similar companies
Read more about Adaptive Biotechnologies (ADPT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Adaptive Biotechnologies?
The Market Cap of Adaptive Biotechnologies is $2.61B.
When does Adaptive Biotechnologies report earnings?
Adaptive Biotechnologies will report its next earnings on November 5 '25.
What is the current stock price of Adaptive Biotechnologies?
Currently, the price of one share of Adaptive Biotechnologies stock is $17.22.
How can I analyze the ADPT stock price chart for investment decisions?
The ADPT stock price chart above provides a comprehensive visual representation of Adaptive Biotechnologies' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Adaptive Biotechnologies shares. Our platform offers an up-to-date ADPT stock price chart, along with technical data analysis and alternative data insights.
Does ADPT offer dividends to its shareholders?
As of our latest update, Adaptive Biotechnologies (ADPT) does not offer dividends to its shareholders. Investors interested in Adaptive Biotechnologies should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Adaptive Biotechnologies?
Some of the similar stocks of Adaptive Biotechnologies are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.
